MENU
+Compare
TNXP
Stock ticker: NASDAQ
AS OF
Dec 18, 11:06 AM (EDT)
Price
$0.37
Change
+$0.04 (+12.12%)
Capitalization
62.4M

TNXP Tonix Pharmaceuticals Holding Corp. Forecast, Technical & Fundamental Analysis

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for TNXP with price predictions
Dec 17, 2024

Momentum Indicator for TNXP turns positive, indicating new upward trend

TNXP saw its Momentum Indicator move above the 0 level on December 10, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned positive. In of the 73 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

TNXP moved above its 50-day moving average on November 19, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TNXP crossed bullishly above the 50-day moving average on November 21, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +13 3-day Advance, the price is estimated to grow further. Considering data from situations where TNXP advanced for three days, in of 215 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TNXP moved out of overbought territory on December 17, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 31 cases where TNXP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNXP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TNXP broke above its upper Bollinger Band on December 12, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TNXP entered a downward trend on November 19, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.841) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). TNXP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.515) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TNXP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNXP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TNXP is expected to report earnings to rise 1,617.39% to -395 cents per share on March 17

Tonix Pharmaceuticals Holding Corp. TNXP Stock Earnings Reports
Q4'24
Est.
$-3.95
Q3'24
Beat
by $2.70
Q2'24
Missed
by $14.05
Q1'24
Beat
by $3.04
Q4'23
Est.
$-6.85
The last earnings report on November 12 showed earnings per share of -23 cents, beating the estimate of -293 cents. With 45.12M shares outstanding, the current market capitalization sits at 62.40M.
A.I. Advisor
published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MMC213.180.06
+0.03%
Marsh & McLennan Companies
BC71.42-0.99
-1.37%
Brunswick Corp
SGHC6.61-0.12
-1.78%
Super Group (SGHC) Limited
LFMD5.65-0.17
-2.92%
LifeMD
EBON7.31-0.29
-3.82%
Ebang International Holdings

TNXP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with ICU. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then ICU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-37.00%
ICU - TNXP
77%
Closely correlated
+8.15%
TOVX - TNXP
35%
Loosely correlated
+1.71%
CRVS - TNXP
32%
Poorly correlated
+7.10%
BOLD - TNXP
31%
Poorly correlated
+0.80%
RNAZ - TNXP
28%
Poorly correlated
-6.17%
More

Groups containing TNXP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
-37.00%
TNXP
(2 stocks)
35%
Loosely correlated
+5.24%